The association of smoking status with healthcare utilisation, productivity loss and resulting costs: Results from the population-based KORA F4 study

BMC Health Services Research

Volumn 13, Issue 1, 2013, Pages

  Wacker, Margarethe ^a   Holle, Rolf ^a   Heinrich, Joachim ^a   Ladwig, Karl Heinz ^a   Peters, Annette ^a   Leidl, Reiner ^a,b   Menn, Petra ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bottom up approach; Direct and indirect costs; Germany; Healthcare utilisation; Smoking

Indexed keywords

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; ECONOMICS; FEMALE; GERMANY; HEALTH CARE COST; HEALTH SERVICE; HUMAN; MALE; MIDDLE AGED; SMOKING; STATISTICAL MODEL; STATISTICS; UTILIZATION REVIEW; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; FEMALE; GERMANY; HEALTH CARE COSTS; HEALTH SERVICES; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; SMOKING;

EID: 84880181350     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-13-278     Document Type: Article

References (51)

1. Priority actions for the non-communicable disease crisis. Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, Baugh V, Bekedam H, Billo N, Casswell S, et al. Lancet 2011 377 9775 1438 1447 10.1016/S0140-6736(11)60393-0 21474174
2. U.S. Department of Health and Human Services, The Health Consequences of Smoking: A Report of the Surgeon General Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health 2004
3. Trends in quality-adjusted life-years lost contributed by smoking and obesity. Jia H, Lubetkin EI, Am J Prevent Med 2010 38 2 138 144 10.1016/j.amepre.2009.09.043
4. Smoking and health-related quality of life in English general population: implications for economic evaluations. Vogl M, Wenig C, Leidl R, Pokhrel S, BMC Public Health 2012 12 1 203 10.1186/1471-2458-12-203 22429454
5. World Health Organization, WHO report on the global tobacco epidemic, 2009: Implementing smoke-free environments Geneva: World Health Organization 2009
6. The financial impact of smoking on health-related costs: a review of the literature. Max W, Am J Health Promot 2001 15 5 321 331 10.4278/0890-1171-15.5. 321 11502013
7. Bank W, Curbing the Epidemic: Governments and the Economics of Tobacco Control Washington: The World Bank 1999
8. Smoking-recent trends in adults. Lampert T, GBE kompakt 2 (4)-Zahlen und Trends aus der Gesundheitsberichterstattung des Bundes Berlin: Robert Koch-Institut 2011
9. Disparities in health care utilization by smoking status-NHANES 1999-2004. Kahende JW, Adhikari B, Maurice E, Rock V, Malarcher A, Int J Environmen Res Public Health 2009 6 3 1095 1106 10.3390/ijerph6031095
10. The impact of smoking and quitting on health care use. Wagner EH, Curry SJ, Grothaus L, Saunders KW, McBride CM, Arch Int Med 1995 155 16 1789 1795 10.1001/archinte.1995.00430160133013
11. Does smoking increase sick leave? Evidence using register data on Swedish workers. Lundborg P, Tobacco Control 2007 16 2 114 118 10.1136/tc.2006.017798 17400949
12. Short term effects of cigarette smoking on hospitalisation and associated lost workdays in a young healthy population. Robbins AS, Fonseca VP, Chao SY, Coil GA, Bell NS, Amoroso PJ, Tobacco Control 2000 9 4 389 396 10.1136/tc.9.4.389 11106708
13. Smoking and absence from work: systematic review and meta-analysis of occupational studies. Weng SF, Ali S, Leonardi-Bee J, Addiction 2013 108 2 307 319 10.1111/add.12015 23078132
14. Health care costs among smokers, former smokers, and never smokers in an HMO. Fishman PA, Khan ZM, Thompson EE, Curry SJ, Health Serv Res 2003 38 2 733 749 10.1111/1475-6773.00142 12785570 (Pubitemid 36570037)
15. Smoking-related costs among 25 to 59 year-old males in a 19-year individual follow-up. Kiiskinen U, Vartiainen E, Puska P, Pekurinen M, Eur J Public Health 2002 12 2 145 151 10.1093/eurpub/12.2.145 12073754 (Pubitemid 34664151)
16. Mortality in relation to smoking: 50 years' observations on male British doctors. Doll R, Peto R, Boreham J, Sutherland I, BMJ 2004 328 7455 1519 10.1136/bmj.38142.554479.AE 15213107
17. Cigarette smoking and lifetime medical expenditures. Hodgson TA, Milbank Quarterly 1992 70 1 81 125 10.2307/3350086 1588892
18. The total lifetime costs of smoking. Rasmussen SR, Prescott E, Sorensen TI, Sogaard J, Eur J Public Health 2004 14 1 95 100 10.1093/eurpub/14.1.95 15080400 (Pubitemid 38523670)
19. The total lifetime health cost savings of smoking cessation to society. Rasmussen SR, Prescott E, Sorensen TI, Sogaard J, Eur J Public Health 2005 15 6 601 606 10.1093/eurpub/cki024 16014659 (Pubitemid 41790243)
20. The cost of smoking for the healthcare system and society in Germany. Adams M, Effertz T, Alkohol, Tobacco and Complications Stuttgart: Thieme Verlag 2010 57 64
21. Mortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison. Neubauer S, Welte R, Beiche A, Koenig HH, Buesch K, Leidl R, Tobacco Control 2006 15 6 464 471 10.1136/tc.2006.016030 17130376 (Pubitemid 44935574)
22. The costs of health damage and productivity losses attributable to cigarette smoking in Germany. Welte R, König H, Leidl R, Eur J Public Health 2000 10 1 31 38 10.1093/eurpub/10.1.31 (Pubitemid 30182900)
23. The economic impact of smoking in Germany. Ruff LK, Volmer T, Nowak D, Meyer A, Eur Respiratory J 2000 16 3 385 390 10.1034/j.1399-3003.2000.016003385. x
24. [Modelling of the costs of productivity losses due to smoking in Germany for the year 2005]. Prenzler A, Mittendorf T, von der Schulenburg JM, Gesundheitswesen 2007 69 11 635 643 10.1055/s-2007-992781 18080936
25. Smoking-attributable productivity loss in Germany-a partial sickness cost study based on the human capital potential method. Wegner C, Gutsch A, Hessel F, Wasem J, Gesundheitswesen 2004 66 7 423 432 10.1055/s-2004-813326 15314734 (Pubitemid 39099869)
26. Economic productivity losses as a result of smoking-an analysis under consideration of the friction cost method. Wegner C, Gutsch A, Hessel F, Wasem J, Gesundh ökon Qual manag 2005 10 6 356 364 10.1055/s-2005-858150 23687408 (Pubitemid 43019172)
27. World Health Organization, Economics of Tobacco Toolkit-Assessment of the Economic Costs of Smoking Geneva: World Health Organization 2011
28. KORA-a research platform for population based health research. Holle R, Happich M, Lowel H, Wichmann HE, Gesundheitswesen 2005 67 Suppl 1 19 S25 16032513
29. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Rathmann W, Haastert B, Icks A, Lowel H, Meisinger C, Holle R, Giani G, Diabetologia 2003 46 2 182 189 12627316 (Pubitemid 36343881)
30. World Health Organization, Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors Geneva: World Health Organization 2004
31. Direct medical costs of COPD-An excess cost approach based on two population-based studies. Menn P, Heinrich J, Huber RM, Jorres RA, John J, Karrasch S, Peters A, Schulz H, Holle R, Respir Med 2012 106 4 540 548 10.1016/j.rmed.2011.10.013 22100535
32. Empirical standard costs for health economic evaluation in Germany-a proposal by the working group methods in health economic evaluation. Krauth C, Hessel F, Hansmeier T, Wasem J, Seitz R, Schweikert B, Gesundheitswesen 2005 67 10 736 746 10.1055/s-2005-858698 16235143 (Pubitemid 41604934)
33. National Association of Statutory Health Insurance Physicians http://www.kbv.de/2398.html
34. Federal Statistical Office, [Hospital statistics on capacity utilisation] https://www.destatis.de/DE/Publikationen/Thematisch/Gesundheit/Krankenhaeuser/ GrunddatenKrankenhaeuser2120611117004.pdf?-blob=publicationFile
35. Federal Statistical Office, Statistical Yearbook 2008 for the Federal Republic of Germany Wiesbaden: Federal Statistical Office 2009
36. German Pension Fund, Statistics on Rehabilitation in 2008 Berlin: German Pension Fund 2009
37. Research Institute of the AOK http://wido.de/arzneimittel.html
38. German recommendations on health economic evaluation: third and updated version of the Hanover Consensus. Graf Von Der Schulenburg JM, Greiner W, Jost F, Klusen N, Kubin M, Leidl R, Mittendorf T, Rebscher H, Schoeffski O, Vauth C, et al. Value Health 2008 11 4 539 544 10.1111/j.1524-4733.2007.00301.x 18194408 (Pubitemid 352032814)
39. The friction cost method for measuring indirect costs of disease. Koopmanschap MA, Rutten FFH, van Ineveld BM, van Roijen L, J Health Econ 1995 14 2 171 189 10.1016/0167-6296(94)00044-5 10154656
40. Federal Statistical Office, National Accounts-Compensation per Employee, Gross Wages and Salaries Wiesbaden: Federal Statistical Office 2011
41. Multiple regression of cost data: use of generalised linear models. Barber J, Thompson S, J Health Serv Res Policy 2004 9 4 197 204 10.1258/1355819042250249 15509405 (Pubitemid 39424759)
42. Methods for analyzing health care utilization and costs. Diehr P, Yanez D, Ash A, Hornbrook M, Lin DY, Ann Rev Public Health 1999 20 125 144 10.1146/annurev.publhealth.20.1.125 (Pubitemid 29242574)
43. Impact of smoking habit on medical care use and its costs: a prospective observation of National Health Insurance beneficiaries in Japan. Izumi Y, Tsuji I, Ohkubo T, Kuwahara A, Nishino Y, Hisamichi S, Int J Epidemiol 2001 30 3 616 621 10.1093/ije/30.3.616 11416093 (Pubitemid 32600260)
44. Smoking and use of primary care services: findings from a population-based cohort study linked with administrative claims data. Jorm L, Shepherd L, Rogers K, Blyth F, BMC Health Servi Res 2012 12 1 263 10.1186/1472-6963-12-263
45. Changes in health care costs before and after smoking cessation. Fishman PA, Thompson EE, Merikle E, Curry SJ, Nicotine Tob Res 2006 8 3 393 401 10.1080/14622200600670314 16801297 (Pubitemid 43977041)
46. Empirical analysis shows reduced cost data collection may be an efficient method in economic clinical trials. Seidl H, Meisinger C, Wende R, Holle R, BMC Health Serv Res 2012 12 1 318 10.1186/1472-6963-12-318 22978572
47. Patient self-reports in pharmacoeconomic studies. Their use and impact on study validity. Evans C, Crawford B, Pharmacoeconomics 1999 15 3 241 256 10.2165/00019053-199915030-00004 10537432 (Pubitemid 29133461)
48. Prolonged recruitment efforts in health surveys: effects on response, costs, and potential bias. Holle R, Hochadel M, Reitmeir P, Meisinger C, Wichmann HE, Epidemiol 2006 17 6 639 643 10.1097/01.ede.0000239731.86975.7f (Pubitemid 44655600)
49. WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment 2010 Oslo: World Health Organization 2009
50. Federal Ministry of Health, Statutory Health Insurance-Final accounting results 2008 http://www.bmg.bund.de/fileadmin/redaktion/pdf-statistiken/ krankenversicherung/kj-2008-endgueltige-rechnungsergebnisse.pdf
51. World Health Organization, WHO Framework Convention on Tobacco Control Geneva: World Health Organization 2003